Stem Cell Transplant Clinical Trial
Official title:
Safety and Immunogenicity of Shingrix Administered to Recipients of Allogeneic Peripheral and Cord Blood Stem Cell Transplants: Effect of Timing of Vaccination After Transplantation
This research is designed to determine if the adjuvanted recombinant glycoprotein E (gE) herpes zoster (HZ) vaccine (Shingrix) has acceptable immunogenicity and safety in people who have undergone allogeneic stem cell transplant (allo-SCT). Specifically, it will determine the effect of the interval after transplantation on the immune response and if an additional dose of vaccine is needed to improve the vaccine-induced responses.
This is a phase II, single center, prospective, unblinded, immunogenicity and safety study. It is anticipated that enrollment will take approximately 6 months. Duration of participation for study subjects is approximately 1 year. During this interval, participants will continue to receive clinical care from the BMT center, which will ensure retention. Participants will be recruited at their routine clinic visits, which take place every 6 months post-transplantation, or will be recruited by phone. Participants will be consented by study personnel in coordination with the BMT health care providers and subsequently followed in Dr. Levin's Vaccine Research Clinic, where they will also receive the 3rd dose of vaccine. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03641378 -
Inpatient Palliative Care for Patients Undergoing Hematopoietic Stem Cell Transplantation
|
N/A | |
| Recruiting |
NCT06155188 -
Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia
|
N/A | |
| Recruiting |
NCT03562065 -
Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord
|
Phase 1/Phase 2 | |
| Completed |
NCT01468935 -
Bone Marrow Cell Engraftment of the Uterus and Genetic Studies of Reproductive Functioning
|
||
| Active, not recruiting |
NCT03938324 -
Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions
|
N/A | |
| Completed |
NCT04219657 -
Comparison Between Skin Graft Versus Skin Graft and Stem Cell Application
|
Phase 1 | |
| Not yet recruiting |
NCT03259217 -
Clinical Application of Mesenchymal Stem Cells Seeded in Chitosan Scaffold for Diabetic Foot Ulcers
|
Phase 1 | |
| Recruiting |
NCT01189786 -
Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection
|
N/A | |
| Recruiting |
NCT04610359 -
Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis
|
Phase 1 | |
| Completed |
NCT05712148 -
Spheroidal Mesenchymal Stem Cells in Retinitis Pigmentosa
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05515497 -
BMT4me: Post-HSCT Medication Adherence mHealth App
|
N/A | |
| Completed |
NCT01984671 -
Mobile Pain Coping Skills Training for Stem Cell Transplant Patients
|
N/A | |
| Not yet recruiting |
NCT06075927 -
Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT
|
Phase 1/Phase 2 | |
| Completed |
NCT03440775 -
Digital Stories and Psychosocial Wellbeing in Stem Cell Transplant Patients
|
N/A | |
| Recruiting |
NCT02652052 -
Hematopoietic Stem Cell Transplant Survivors Study
|
N/A | |
| Not yet recruiting |
NCT04922970 -
Strength Training as Prevention and Treatment of Late Effects in Long-term Survivors of Pediatric HSCT.
|
N/A | |
| Completed |
NCT01092195 -
Gardasil Vaccination in Post Stem Cell Transplant Patients
|
Phase 1 | |
| Completed |
NCT04041219 -
Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patients
|
Phase 4 | |
| Completed |
NCT00656058 -
Montelukast to Treat Bronchiolitis Obliterans
|
Phase 2 | |
| Recruiting |
NCT04375579 -
Assessment of Elderly Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
|